Description
DE-OBLIGATED FUNDS QUOTIENT BRAND BLOOD REAGENTS&SUPPLIES.
Base award description: QUOTIENT BRAND BLOOD REAGENTS&SUPPLIES.
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$31,744= $31,744
- Mod P000012021-11-08-$13,520= $18,224
- Mod P000032022-01-31-$1,451= $16,774
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$31,744 | $31,744 | QUOTIENT BRAND BLOOD REAGENTS&SUPPLIES. |
| Mod P00001· FUNDING ONLY ACTION | 2021-11-08 | −$13,520 | $18,224 | QUOTIENT BRAND BLOOD REAGENTS&SUPPLIES. |
| Mod P00003· FUNDING ONLY ACTION | 2022-01-31 | −$1,451 | $16,774 | DE-OBLIGATED FUNDS QUOTIENT BRAND BLOOD REAGENTS&SUPPLIES. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V6KNKL6BDHL7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0306 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $40,949 | FY2026 |
| 36C25926N0280 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $64,078 | FY2026 |
| 36C25726N0176 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $7,634 | FY2026 |
| 36C25726N0224 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $16,514 | FY2026 |
| 36C25626N0214 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $23,127 | FY2026 |
| 36C25026N0043 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,884 | FY2026 |
Other recipients under 6640 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926N0474 | LEICA MICROSYSTEMS INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $200,000 | FY2026 |
| 36C25926F0276 | BIOMERIEUX INC | NETWORK CONTRACT OFFICE 19 (36C259) | $60,940 | FY2026 |
| 36C25926N0454 | BECTON, DICKINSON AND COMPANY | NETWORK CONTRACT OFFICE 19 (36C259) | $114,883 | FY2026 |
| 36C25926N0438 | ROCHE DIAGNOSTICS CORPORATION | NETWORK CONTRACT OFFICE 19 (36C259) | $34,878 | FY2026 |
| 36C25926N0437 | ROCHE DIAGNOSTICS CORPORATION | NETWORK CONTRACT OFFICE 19 (36C259) | $35,030 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25920N0018_3600_VA25917A0069_3600 · retrieved 2026-09-26.